Reshaping the way we look at neurodegenerative disease.
Advanced imaging technology has quickly evolved to the point where it has altered the way we view the brain and neurodegenerative disease. This installment of Existential Medicine will explore how transformative technology has reshaped scientific beliefs, informed basic research, and driven patient care decisions.
Dan Seewald – CEO, Deliberate Innovation
Paul MacCracken – VP and Head of Medical Imaging, ICON PLC
Mackenzie Mathis – Director of Motor Control Labs, Bertarelli Foundation Chair of Integrative Neuroscience
Hartmuth Kolb – VP, Neuroscience Biomarkers and Janssen R&D Global Imaging
About the Organizers
Visited 38 times, 3 Visits today